Rexulti (Brexpiprazole): Indications, Dosage, Side Effects, and Safety Information

Rexulti (brexpiprazole) is prescribed for major depressive disorder (as adjunct therapy), schizophrenia, and agitation associated with Alzheimer’s‑related dementia. It is taken daily; intermittent use for agitation is not recommended.

Note for caregivers: As a patient’s condition evolves, they may need assistance understanding their treatment plan. The information below is intended to help caregivers and patients alike.

Medication basics

Rexulti contains the active ingredient brexpiprazole and is available only as a brand‑name tablet (no generic). Clinical studies have shown it to be safe and effective for depression, schizophrenia, and dementia‑related agitation.

Like any medication, Rexulti can cause side effects that vary with age, other health conditions, and concomitant drugs. Your prescriber or pharmacist can provide a complete side‑effect profile and strategies to mitigate them.

Reporting side effects: The FDA monitors post‑marketing safety. If you experience an adverse reaction, you can report it to MedWatch (https://www.fda.gov/safety/medwatch) or call 800‑332‑1088.

Mild side effects

Common mild reactions include headache, nausea, insomnia, and mild weight changes. These often resolve within days to weeks. If they persist or become bothersome, contact your healthcare provider.

Serious side effects

Serious, but uncommon, reactions may include:

• Sexual urges or compulsive behaviors
• Metabolic changes (type 2 diabetes, lipid abnormalities)
• Increased risk of stroke
• Tardive dyskinesia (involuntary movements)
• Neuroleptic malignant syndrome – rapid heart rate, high fever, muscle rigidity (medical emergency)
• Low white‑blood‑cell count
• Orthostatic hypotension, fainting, falls
• Seizures
• Temperature regulation problems
• Difficulty swallowing
• Slowed thinking or reflexes – use caution when driving or operating machinery
• Boxed warnings (see below)
• Allergic reactions – rash, itching, swelling, or breathing difficulty

If you suspect a serious reaction, call your doctor immediately or dial 911.

Boxed warnings

Increased mortality in older adults with dementia‑related psychosis

Rexulti is not recommended for patients ≥ 65 years with psychosis linked to dementia, as studies showed a higher risk of death, primarily from cardiovascular events or infections. The drug may be used for agitation in Alzheimer’s‑related dementia only when the benefits outweigh the risks.

Suicidal thoughts and behaviors

All antipsychotics, including Rexulti, can increase suicidal ideation in individuals ≤ 24 years. While Rexulti is not FDA‑approved for depression in children, it is approved for schizophrenia in patients ≥ 13 years. Discuss any history of suicidal thoughts with your prescriber.

Allergic reactions

Symptoms range from mild rash or itching to severe swelling of the face, lips, tongue, or throat. Seek immediate medical attention for severe reactions.

Approved uses

• Major depressive disorder (MDD): Used as adjunctive therapy with an antidepressant. Typical maximum dose = 3 mg daily.
• Schizophrenia: Adults and adolescents ≥ 13 years. Maximum dose = 4 mg daily.
• Agitation due to Alzheimer’s‑related dementia: Adults only. Maximum dose = 3 mg daily.

Formulation and strengths

Oral tablets are available in 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg strengths.

Typical dosing schedules

• Depression: Start 0.5 mg daily; titrate to a maximum of 3 mg once daily.
• Schizophrenia: Days 1‑4 = 1 mg daily; Days 5‑7 = 2 mg daily; may increase to 4 mg daily as needed.
• Agitation (dementia): Days 1‑7 = 0.5 mg daily; Days 8‑14 = 1 mg daily; may increase to 3 mg daily.
• Children (schizophrenia ≥ 13 yr): Days 1‑4 = 0.5 mg daily; Days 5‑7 = 1 mg daily; may increase to 4 mg daily.

Always follow the exact regimen prescribed by your clinician.

Administration tips

• Swallow tablets whole; do not crush, chew, or split.
• Can be taken with or without food.
• If a dose is missed, take it as soon as remembered unless it is near the time of the next dose—then skip the missed dose.
• Do not double‑dose.

Drug interactions

Rexulti is metabolized by hepatic enzymes (CYP2D6, CYP3A4). Concomitant drugs that inhibit these enzymes (e.g., fluoxetine, ketoconazole) may increase brexpiprazole levels, while strong inducers (e.g., carbamazepine, rifampin) may reduce its effectiveness. Inform your prescriber of all prescription, over‑the‑counter, herbal, and supplement use—particularly St. John’s wort, which can diminish Rexulti’s effect.

Alcohol and Rexulti

Alcohol can intensify sedation, dizziness, and liver strain. Discuss alcohol use with your clinician.

Pregnancy, lactation, and reproductive considerations

Use in the third trimester may increase the risk of extrapyramidal symptoms or withdrawal in the newborn. Safety during breastfeeding is unknown. Discuss family planning and pregnancy status with your provider before initiating therapy.

Overdose

If an overdose is suspected, contact your doctor, call 800‑222‑1222 (Poison Center), or seek emergency care (911).

Key questions for your provider

• How will Rexulti affect my daily functioning and mood?
• What monitoring is required (e.g., blood glucose, lipids, blood counts)?
• Are there specific drug‑interaction concerns with my current medications?
• What should I do if I notice side effects?

Bring a written list of questions and, if helpful, a companion to your appointment.

Comparisons with similar agents

Rexulti belongs to the atypical (second‑generation) antipsychotic class, like Abilify (aripiprazole), Latuda (lurasidone), Vraylar (cariprazine), and Seroquel (quetiapine). While they share a common mechanism of modulating dopamine and serotonin, each has distinct active ingredients, dosing ranges, and FDA‑approved indications. Discuss with your clinician which agent best fits your clinical profile.

Withdrawal

Rexulti does not produce physical dependence; abrupt discontinuation will not cause classic withdrawal symptoms, but disease symptoms may rebound. Tapering under medical supervision is recommended.

Cost and assistance

Out‑of‑pocket costs vary by insurance and pharmacy. The manufacturer offers a savings card and patient‑assistance programs—see the Rexulti website for details.

Disclaimer: This information is for educational purposes and does not replace professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.

Rexulti images